Treatment of congenital non‐ductal shunt lesions with the amplatzer duct occluder II

Abstract

Use of the ADO II in non-ductal positions can be achieved with high success and low complication rates, especially CHB; its use is also associated with significantly reduced procedure time and device cost. Device size availability restricts use of the ADO II to defects up to 6 mm in diameter. © 2013 Wiley Periodicals, Inc.

ADO II in Percutaneous VSD Closure in Pediatric Patients

“…Also this could be due to the design of the ADO II device which is soft in nature with no polyester material that does not apply a direct force on conduction system. This property of the device was previously emphasized by Vijayalakshmi et al In that study, only three cases developed transient junctional bradycardia in that study and only one patient with Gerbode defect developed transient complete heart block (1.3%), none of the patients had complete heart block …”

“…This property of the device was previously emphasized by Vijayalakshmi et al In that study, only three cases developed transient junctional bradycardia in that study and only one patient with Gerbode defect developed transient complete heart block (1.3%), none of the patients had complete heart block. 15 Another clue for succesful transcatheter closure of VSD is the location of the defect. It has to be remote from the tricuspid and aortic valves, with an adequate rim.…”

Amplatzer duct occluder ii for closure of congenital Gerbode defects

“…In their series, one patient developed complete heart block, requiring permanent pacemaker implantation . We had reported the transcatheter closure of four cases of congenital Gerbode defects earlier .…”

“…These shunts are traditionally closed surgically with high incidence of complete heart block. There are case reports and small series of mostly acquired and few congenital Gerbode defects closed percutaneously with various types of devices . We report a small series of 12 cases of only congenital Gerbode defects closed with Amplatzer duct occluder II (ADO II) which is specially designed to close long tubular duct in infants.…”

Transcatheter closure of an iatrogenic ventricular septal defect after SAPIEN valve implantation

“…We describe a patient who developed a ventricular septum defect (VSD) in the perimembranous area during transapical aortic valve replacement with a 23 mm SAPIEN valve. Although many perimembranous VSDs (pmVSD) continue to be closed surgically, there are well‐established techniques for closure of pmVSDs by catheter‐based techniques . In most patients in whom TAVR is performed rather than surgery, transcatheter VSD closure will usually be preferable.…”